Sun Pharmaceutical Industries will purchase Taro’s outstanding shares for $43 each, which will total $348 million.
Sun Pharma and Taro Reach Definitive Merger Agreement
![](https://onclive.s3.amazonaws.com/onclive_630x1200.png)
Estimated read time
1 min read
Sun Pharmaceutical Industries will purchase Taro’s outstanding shares for $43 each, which will total $348 million.
+ There are no comments
Add yours